Ireland
--:--IST
Latest
Clinical Trials in Canada / NCT06804694
Recruiting Not applicable

Technology-Enabled Collaborative Care for Young Adults With Type 1 Diabetes and Diabetes Distress: A Feasibility Trial

NCT06804694 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2024-11-27
Last updated
2025-02-03

Condition(s) studied

Type 1 Diabetes (T1D)Diabetes Distress

Investigational drug(s) / intervention(s)

TECC-T1D3 ProgramEducation Intervention

TECC-T1D3 Program: The TECC-T1D3 program is a twelve-week virtual care intervention designed to support individuals with Type 1 Diabetes (T1D) and Diabetes Distress. The program includes a health coach (HC) and a virtual care team (VCT) of T1D, mental health experts and peer support, offering comprehensive care through various communication channels, including WebEx, phone calls, and text messaging. The program aims to: i. Provide T1D specific mental health and wellbeing support, ii. Provide guidance on how to communicate with others about T1D, manage stigma and ask for help with diabetes management and iii. Facilitate connections with T1D communities. Participants can choose topics of discussion based on their needs and will be directly supported by the HC and indirectly monitored by VCT.

Education Intervention: The Education Intervention is a low-intensity, education-focused intervention consisting of 10 automated emails over 12 weeks, providing generalized educational messages with links to resources for mental health support and well-being for individuals living with T1D.

Study summary

The goal of the study is to evaluate the acceptability and feasibility of a co-designed, Technology-Enabled Collaborative Care for Young Adults with Type-1 Diabetes and Diabetes Distress (TECC-T1D3) program. Through this program, the investigators aim to deliver a collaborative care intervention, featuring a health coach and a virtual care team, designed to help participants manage mental health and overall wellbeing.

Eligibility

Sex
ALL
Min age
18 Years
Max age
29 Years
Healthy volunteers
No
Inclusion Criteria: * Young adult (age 18-29 years) * Resident of Ontario * Living with a self-reported diagnosis of T1D of at least 1 year * Individual is community-living (people who live independently in the community and are not residing in a setting that provide institutional care or support) Exclusion Criteria: * Unable to participate in English language * Unable to participate via telephone or web-conferencing

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Centre for Addiction and Mental Health Toronto Ontario Recruiting

More Centre for Addiction and Mental Health trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06804694 on ClinicalTrials.gov ↗ ← All trials in Canada